Volver a Agenda
Session Chair(s)
Yasuo Ohashi, PHD
Professor, Dept. of Integrated Science and Engineering for Sustainable Society
Chuo University, Japan
Speaker(s)
An Adaptive, Seamless Phase 2/3 Study Incorporating a Clinical Utility Index
Zachary Kulkarni Skrivanek, PHD
Eli Lilly and Company, United States
Principal Research Scientist, Global Statistical Sciences
Experience of Sample Size Re-estimation for Registration Studies in Japan
Shintaro Hiro, PHD
Pfizer R&D Japan, Japan
Manager, Data Science & Analytics Japan Lead, Clinical Statistics
A Regulatory Perspective on the Use of Adaptive Design in Drug Development
Hiroyuki Sato, PHD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Reviewer, Office of New Drug V
¿Tiene una cuenta?